Ozempic cuts risk of death from kidney disease, major study finds

Novo Nordisk, the maker of Ozempic will seek FDA approval to dramatically expand the number of patients eligible for the shots.

Related Keywords

Sydney ,New South Wales ,Australia ,United States ,Stockholm ,Sweden ,Americans ,Peter Verdult ,Tricia Neuman ,Daniel Gilbert ,Amandam Hils ,Melanie Jay ,Michael Radin ,Vlado Perkovic ,Drug Administration ,Citigroup ,European Renal Association ,Novo Nordisk ,University Of New South Wales ,Grossman School Of Medicine ,New England Journal ,African Americans ,